Wilmington, NC. – March 2022 Prestige Scientific announces the successfully completed search for a Senior Director of CMC for our biotechnology partner that is focused on expanding the applications for CAR-based therapeutics by employing Novel Cell Engineering & Gene Editing Technologies This Senior Director of CMC will be responsible for providing Program/Project Management expertise and support to our partner's programs to ensure all milestones and deliverables are met, and that tasks are well executed and managed. They will partner with the Academic Founder, PD Lab and leadership to create program plans and budgets, as well as day-to-day planning, coordinating, and tracking of critical activities.
They will also be responsible for driving program timelines to keep programs on schedule and within budget.Client Objectives: Our partner is focused on expanding the applications for CAR-based therapeutics by employing Novel Cell Engineering & Gene Editing Technologies. The initial indication addresses significant unmet therapeutic need for treatment of T-Cell Lymphomas. Project: Prestige Scientific presented the candidate hired within 20 days of starting the project and successfully completed the search within 40 days of project launch. Congratulations to Mike Smith for leading this search! Checkout more of our completed searches on LinkedIn.
About Prestige Scientific: Prestige Scientific provides our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own while overcoming challenges and adhering to critical timelines. This systematic approach has proven to decrease our client’s time-to-fill while increasing hiring accuracy. On average our executive searches are completed in 59 days, with the eventual hire presented to the client by the 9th day of the search, with a success rate of 99.7%. Prestige Scientific team members specialize by Practice Area and are deeply anchored in each discipline. Learn more about our expertise.